Filing metadata

Accession number
0001127602-25-002379
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jan 30, 2025
Reporting period
Jan 29, 2025
Description
Insider transaction

Explore SEC Filings Hub